Clinical and Economic Impact of CMV Infection in Allogeneic Hematopoietic Stem Cell Transplantation: Perspectives from a Middle-Income Nation.
Gin Gin GanThevambiga IyadoraiNoor Yuhyi SulaimanNajihah HusseinHany AriffinPublished in: Clinical transplantation (2024)
This single-center study demonstrated that patients who underwent HLA-haploidentical AHSCT and subsequently developed CMV infection had higher transplantation expenditures compared to those who had matched-related transplantation. Further studies should be conducted to evaluate if primary prophylaxis against CMV is cost-effective, especially in patients who undergo HLA-haploidentical AHSCT.
Keyphrases
- allogeneic hematopoietic stem cell transplantation
- end stage renal disease
- stem cell transplantation
- bone marrow
- ejection fraction
- chronic kidney disease
- newly diagnosed
- acute lymphoblastic leukemia
- acute myeloid leukemia
- peripheral blood
- prognostic factors
- physical activity
- cord blood
- patient reported outcomes
- high dose